NWPF

News Archives

Filtered by: May 2005

Vitamin E cuts Parkinson’s risk

Wednesday May 25, 2005

Good sources of vitamin E include green leafy vegetables, nuts and vegetable oils.

A study in Lancet Neurology pooled available data and found people who ate plenty of these foods in their diet were far less likely to develop Parkinson’s.

Read Article

Nuts and lettuce ’may reduce risk of Parkinson’s’

Wednesday May 25, 2005

EATING more nuts, wheat germ and lettuce may protect against Parkinson’s disease, scientists said today.

Read Article

Scientists Speed Creation of Stem Cells

Wednesday May 25, 2005

South Korean scientists have dramatically sped up the creation of human embryonic stem cells, growing 11 new batches that for the first time were a genetic match for injured or sick patients.

Read Article

Conejo Valley man has learned to live with Parkinson’s disease

Wednesday May 25, 2005

Bob Zeman is a runner. He’s a dancer, a basketball coach, an attorney and a daddy. He’s also a Parkinsonian.

That’s how he referred to people who have Parkinson’s disease when he spoke recently at a Goebel Senior Adult Center seminar.

Read Article

Stem Cell Breakthrough, Possible Treatments for Parkinson’s and Spinal Injuries

Wednesday May 25, 2005


Read Article

The Effects of Parkinson’s Disease on Daily Activities

Wednesday May 25, 2005

The symptoms of Parkinson’s disease—including tremor, difficulty with posture or balance, slowness of movements, and muscle stiffness—become worse over time, even with the best possible treatment. These symptoms may affect a person’s ability to carry out activities of daily living, or ADLs. ADLs include those activities that a person performs as a part of his or her daily routine of self-care, such as bathing, dressing, toileting, and eating. Instrumental ADLs are those activities related to independent living and include the ability to use the telephone, get to places beyond walking distance, go shopping, prepare meals, do housework, do laundry, take medicine, and handle money.

Read Article

Rivastigmine May Be Effective for the Treatment of Dementia in Patients with Parkinson’s Disease

Wednesday May 25, 2005

According to previous research, up to 80% of patients who have Parkinson’s disease for at least eight years may have difficulty with thinking, memory, and processing information, as well as changes in personality and behavior (this is called dementia). The cause of this dementia is not know with certainty.

Read Article

WE MOVE Launches Life in Motion Awareness Campaign

Wednesday May 25, 2005

More than 45 patient advocacy organizations, foundations, and professional societies have joined a coalition in support of the Life in Motion campaign. As is WE MOVE, coalition members are committed to raising awareness about movement disorders, emphasizing the importance of early and accurate diagnosis and illustrating available treatment options.

Read Article

American & European Parkinson’s Disease Patients Can Now Access New Rasagiline (Agilect, Azilect) Drug Treatment From Israe

Wednesday May 25, 2005

Israel is one of the first nations to approve a new Parkinson’s Disease drug called Rasagiline (also called Agilect or Azilect). Now, many American & European patients with the neurodegenerative disease are turning to Isrameds.com, Israel’s only international mail order pharmacy, to obtain the novel treatment.

Read Article

Parkinson’s institute open

Wednesday May 25, 2005

Eyes can now almost literally act as windows to the brain after the opening of a sophisticated Parkinson’s disease research institute.

Read Article
<< Back 1 - 10 of 34 Next >>

Recent News

Sep 12 - Australian Researchers Develop New Diagnostic Tool to Spot Early Signs of Parkinson’s
Sep 11 - GeneFo Webinar to Focus on Using Humor to Manage Parkinson’s Disease
Sep 6 - Parkinson’s and the ‘D’ word
Sep 6 - Compounds in Asthma Drugs Might Be Used as Parkinson’s Treatment
Sep 5 - AstraZeneca Joins Takeda, Berg to Advance Development of Parkinson’s Disease Therapies
Sep 1 - Stem Cell Transplant Trial in Parkinson’s Patients Planned After Test in Japan Succeeds in Monkeys
Sep 1 - Titan to Start Phase 1/2 Study of Subdermal Implant to Deliver Requip to Parkinson’s Patients
Aug 30 - FDA Refuses Acorda’s Inbrija New Drug Application Due to Manufacturing Questions
Aug 23 - Support Groups: Are They for You?
Aug 22 - Internet Visits with Parkinson’s Specialist Can Be as Effective as In-person Visits, Trial Finds
Aug 21 - Cavion’s New CMO to Lead Cav3 Platform Development for Neurological Diseases
Aug 15 - Singing Helps Early-stage Parkinson’s Patients Retain Speech, Respiratory Control, Studies Show
Aug 14 - 16 Tips to Increase Your Mobility Confidence While Living With Parkinson’s Disease
Aug 10 - Boxers are fighting back against Parkinson’s
Aug 9 - Parkinson’s Experiment to Be Aboard Next Flight to International Space Station
Aug 9 - Parkinson’s Disease and Sleeping with the Enemy
Aug 7 - The Importance of Oral Health in Parkinson’s Disease
Aug 7 - Researchers Gain Better Insight Into Alpha-Synuclein’s Role in Parkinson’s Disease
Jul 31 - New Digital Cognitive Assessment Tool Receives Positive FDA Review
Jul 20 - Parkinson’s DREAM Challenge Uses Mobile Sensor Data to Monitor Health Based on Movement